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ABSTRACT
Period2 (Per2) is an essential component of the
mammalian clock mechanism and robust circadian
expression of Per2 is essential for the maintenance
of circadian rhythms. Although recent studies have
shown that the circadian E2 enhancer (a non-
canonical E-box) accounts for most of the circad-
ian transcriptional drive of mPer2, little is known
about the other cis-elements of mPer2 oscillatory
transcription. Here, we examined the contribution
of E4BP4 to Per2 mRNA oscillation in the cell-
autonomous clock. Knockdown experiments of
E4BP4 in both Northern blots and real-time
luciferase assays suggested that endogenous
E4BP4 negatively regulates Per2 mRNA oscillation.
Sequence analysis revealed two putative E4BP4-
binding sites (termed A-site and B-site) on
mammalian Per2 promoter regions. Luciferase
assays with mutant constructs showed that a
novel E4BP4-binding site (B-site) is responsible
for E4BP4-mediated transcriptional repression of
Per2. Furthermore, chromatin immunoprecipitation
assays in vivo showed that the peak of E4BP4
binding to the B-site on the Per2 promoter almost
matched the trough of Per2 mRNA expression.
Importantly, real-time luciferase assays showed
that the B-site in addition to the E2 enhancer is
required for robust circadian expression of Per2
in the cell-autonomous clock. These findings
indicated that E4BP4 is required for the negative
regulation of mammalian circadian clocks.
INTRODUCTION
Physiological and behavioral circadian rhythms are features
of organisms ranging from bacteria to humans and are driven
by an endogenous clock that consists of transcriptional/
translational feedback loops of clock genes (1–4). The ﬁrst
clock mutants were isolated by a forward genetics approach
using eclosion rhythms as a phenotype to clock components
in Drosophila (5). These mutant ﬂies exhibited similar
defects in locomotor activity rhythms and the corresponding
molecular defects were later identiﬁed in the period
(per) gene (6,7). Since then, several additional clock genes,
including timeless, clock, cycle, doubletime and recently
vrille, have been identiﬁed in Drosophila (8–12). Orthologs
of most Drosophila circadian clock genes have been identi-
ﬁed in mammals, highlighting general conservation of the
clock mechanism.
Three mammalian homologues (Per1, Per2 and Per3)o f
the Drosophila circadian clock gene per have been identif-
ied (13–19). Gene targeting studies have demonstrated that
mPer2
Brdm1 mutant mice display a short-circadian period fol-
lowed by a loss of circadian rhythmicity in constant darkness
(20). In contrast, a deletion of mPer1 only shortens the period
length and mPer3 knockout mice have an essentially normal
clock (21,22), indicating that Per2 plays a prominent role
among the three mammalian Per genes. Moreover, constitu-
tively overexpressed mPer2 mRNA rapidly damps cellular
rhythm (23), indicating that robust circadian expression of
Per2 is essential for the maintenance of circadian rhythms.
Recent studies have shown that the circadian E2 enhancer
(a non-canonical E-box) accounts for most of the circadian
transcriptional drive of the mPer2 gene by CLOCK:BMAL1
(24,25), but little is known about the other cis-elements of
mPer2 oscillatory transcription.
The bZIP transcription factor E4BP4 (also called NFIL3)i s
a mammalian homologue of vrille (vri) that functions as a
key negative component of the Drosophila circadian clock
(12,26,27). E4BP4 probably plays an important role in the
phase-delaying process of chickens as a light-dependent
suppressor of cPer2 (28). Although E4BP4 is believed to
be involved in the mammalian circadian clock (25,29,30),
direct evidence has yet to support a requirement for
E4BP4-mediated regulation of these clocks.
Here, we show that E4BP4 functions as a repressor of Per2
transcription through a novel E4BP4-binding site in the
promoter. We also show that E4BP4 binding is required for
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MATERIALS AND METHODS
Cell culture
Mouse ﬁbroblast NIH3T3 cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS) and a mixture of penicillin
and streptomycin at 37 C under a humidiﬁed 5% CO2
atmosphere.
Small interfering RNA (siRNA)
We designed E4BP4 siRNA for knockdown experiments
using BLOCK-iT
TM RNAi Designer (https://rnaidesigner.
invitrogen.com/rnaiexpress/), and BLOCK-iT Fluorescent
Oligo (Invitrogen) served as a control. These oligonucleotides
were introduced into NIH3T3 cells at a ﬁnal concentration
of 10 nM using X-treamGENE (Roche Diagnostics) or
Lipofectamine 2000 (Invitrogen) according to the suppliers’
protocols.
Western blotting
NIH3T3 cells were transfected with the expression vectors,
Myc-tagged E4BP4 or Myc-tagged HLF after siRNA
manipulation. After a 24 h incubation, proteins were sepa-
rated on 10% SDS–PAGE gels (31) and transferred to nitro-
cellulose membranes (Bio-Rad). After blocking nonspeciﬁc
binding with 3% dry milk in PBS, proteins were probed
with anti-Myc monoclonal antibody (clone 9E10; Roche
Diagnostics) and then incubated with a horseradish
peroxidase-conjugated anti-mouse IgG (Upstate). Immunore-
active proteins were visualized using ECL (Amersham Bio-
sciences) according to the manufacturer’s instructions. The
same membrane was reprobed with anti-actin antibody
(clone C4, CHEMICOM).
Northern blotting
Total RNA was prepared using ISOGEN (Nippon Gene)
and then poly(A)
+ RNA was puriﬁed using a GenElute
mRNA Miniprep Kit (Sigma-Aldrich). Northern blotting
proceeded as described (32). Probes labeled with
32P were
generated from cDNA fragments of Per2 (bases 1123–
1830; GenBank accession no. AF036893), E4BP4 (bases
61–770; GenBank accession no. U83148), Bmal1 (bases
231–910; GenBank accession no. AF015953) and b-actin.
The relative expression level of each gene to that of b-actin
was calculated using Image Gauge (FUJIFILM).
Real-time luciferase assay
Fragments of DNA containing the Per2 promoter region and
its derivatives were cloned into pGL3-dLuc that contains a
rapid degradation domain modiﬁed from mouse ornithine
decarboxylase at the carboxy-terminal end of ﬁreﬂy luciferase
(33). After transfecting reporter plasmids using PolyFect
(Qiagen), NIH3T3 cells were stimulated with 100 nM dexam-
ethasone for 2 h and then incubated with DMEM containing
0.1 mM luciferin (Promega), 25 mM HEPES (pH 7.2) and
10% FBS. Bioluminescence was measured and integrated
for 1 min at intervals of 10 min using Kronos AB-2500
(ATTO).
Transient luciferase assay
The Per2 promoter region containing E4BP4-binding sites
and its derivatives were cloned into pGL3-Basic vector
(Promega). The constructs were co-transfected with phRG-
TK (Promega) as an internal control into NIH3T3 cells.
Luciferase activities were measured using the Dual-
Luciferase Reporter Assay System (Promega) and a Lumi-
nometer Model TD-20/20 (Turner Designs). The trans-
criptional activities were normalized relative to Renilla
luciferase activities.
Gel shift assay
Gel shifts were examined as described (34). Brieﬂy, nuclear
extracts were puriﬁed from NIH3T3 cells using CelLytic
NuCLEAR EXTRACTION KIT (Sigma). Recombinant-
E4BP4 was purchased from ABNOVA. The probes (A-site,
from  251 to  92; B-site, from +112 to +332 of mPer2)
were ampliﬁed using the following primer sets: A-site,
50-GGAAGTGGACGCGCCTACTCG-30 (forward) and 50-
CGGAACCTGAGAGCTACGCTC-30 (reverse); B-site,
50-TTGACGCGGCGAAGCGGTGAGTG-30 (forward) and
50-GGGACGCAGTGTGAACCTGG-30 (reverse). Nucleotide
sequences of the 16-bp oligonucleotide probes for the A-
and B-sites were 50-CGTCTTATGTAAAGAG-30 and 50-
CGTCTTACGTAACCGG-30, respectively. These probes
were end-labeled with [g-
32P]ATP using T4 polynucleotide
kinase (New England BioLabs). The DNA probes were sus-
pended in 10 ml of 16 mM HEPES (pH 7.5), 150 mM KCl,
16% (v/v) glycerol, 1.6 mM MgCl2, 0.8 mM dithiothreitol,
0.4 mM PMSF, 1 mM EDTA, 0.8 mg/ml BSA, 0.06 mg/ml
poly(dI–dC) and 0.01% NP-40 in the presence of or absence
of competitor oligonucleotides and incubated with the
nuclear extracts or E4BP4 protein. The anti-E4BP4 antibody
was also added for super-shift assays. The samples were
resolved by electrophoresis on 4% polyacrylamide gels in
40 mM Tris–acetate, 1 mM EDTA and 5% glycerol at
110 V for 2 h.
Chromatin immunoprecipitation (ChIP) assay
Assays of ChIP proceeded as described (34). Brieﬂy, NIH3T3
cells were cross-linked with 1% formaldehyde for 15 min at
room temperature and then washed twice with ice-cold PBS.
The cells were shattered with lysis buffer (25 mM Tris-HCl
(pH 8.0), 140 mM NaCl, 1% Triton X-100, 0.1% SDS,
3 mM EDTA and 1 mM PMSF) on ice for 30 min. Sonication
to shear DNA into 100–300 bp fragments was followed by
centrifugation and supernatants containing soluble chromatin
were collected. The chromatin fraction was incubated with
anti-E4BP4 antibody (E-16, Santa Cruz Biotechnology) over-
night at 4 C, followed by salmon sperm DNA/protein G agar-
ose (Upstate). Chromatin immunocomplexes were washed
three times, once with wash buffer 1 (20 mM Tris-HCl (pH
8.0), 150 mM NaCl, 0.1% SDS, 1% Triton X-100 and
2 mM EDTA), once with wash buffer 2 (20 mM Tris-HCl
(pH 8.0), 500 mM NaCl, 0.1% SDS, 1% Triton X-100
and 2 mM EDTA) and once with wash buffer 3 (10 mM
Tris-HCl (pH 8.0), 0.25 M LiCl, 1% Nonidet P-40, 1%
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for 5 min. The samples were then washed twice with TE buf-
fer. The immunocomplexes were removed with 1% SDS and
0.1 M NaHCO3 and then heated overnight at 65 C to reverse
the crosslinks. The crosslinks of DNA input samples were
similarly reversed. Sample DNA was puriﬁed and then puta-
tive E4BP4 target regions (A-site, from  251 to  92; B-site,
from +112 to +332 of mPer2) were ampliﬁed by PCR using
the following primer sets: A- site, 50-GGAAGTGGACGCG-
CCTACTCG-30 (forward) and 50-CGGAACCTGAGAGCT-
ACGCTC-30 (reverse); B-site, 50-TTGACGCGGCGAAGCG-
GTGAGTG-30 (forward) and 50-GGGACGCAGTGTGAAC-
CTGG-30 (reverse).
RESULTS
E4BP4 down-regulates Per2 transcription
E4BP4 is a mammalian homologue of vrille (vri) that
functions as a key negative component of the Drosophila
circadian clock (12,26,27). However, whether or not E4BP4
is required for mammalian circadian clocks remains unclear.
We initially examined the effect of E4BP4 upon Per2 tran-
scription. To determine whether E4BP4 regulates Per2 gene
expression, we performed knockdown experiments using
small interfering RNA (siRNA) for E4BP4 (E4BP4 siRNA).
The induction of E4BP4 siRNA into NIH3T3 cells resulted
in a signiﬁcant decrease in the protein level of exogenously
expressed Myc-tagged E4BP4, whereas the level of Myc-
tagged Hepatic Leukemia Factor (HLF) was not affected
(Figure 1A, lane 2), suggesting that the siRNA speciﬁcally
knocked down E4BP4. We then examined the mRNA levels
of E4BP4 and Per2 by Northern blotting. After introducing
E4BP4 siRNA into NIH3T3 cells, the mRNA level of
endogenous E4BP4 decreased to  60% of that in non-
transfected (NT) cells (Figure 1B, lane 5). On the other
hand, that of Per2 increased to  130% of that in NT cells
(Figure 1B, lane 6). The levels of neither E4BP4 mRNA
(Figure 1B, lane 3) nor Per2 mRNA (Figure 1B, lane 4)
were affected by induction with scrambled siRNA (Control
siRNA). These results suggest that E4BP4 suppresses Per2
transcription.
The circadian clock is cell-autonomous (35,36). Circadian
oscillators are located not only in the suprachiasmatic nucleus
(SCN) of the brain, which is the central circadian pacemaker
in mammals, but also in most peripheral tissues (19,37,38)
and even in established cell lines (39). To examine the
role of E4BP4 on the circadian expression of Per2 in the
cell-autonomous clock, we performed real-time luciferase
assays (33,40) in NIH3T3 cells using the reporter plasmid
containing the mPer2 ( 798 to +331) promoter to drive
destabilized luciferase (mPer2-dLuc). The transcriptional
start site (TSS) is indicated as +1 (24). After the introduction
of E4BP4 siRNA, the cells were transfected with mPer2-
dLuc and circadian gene expression was induced with
100 nM dexamethasone (41). We measured bioluminescence
in the presence of luciferin and integrated signals for 1 min
at intervals of 10 min. As reported (24,25,30), the transcrip-
tional ﬂuctuation from mPer2-dLuc showed robust circadian
oscillation. The induction of E4BP4 siRNA caused a remark-
able overall 1.86-fold increase in the transcriptional activity
of mPer2-dLuc compared with Control siRNA (Figure 2A).
Conversely, exogenously expressed E4BP4 resulted in a
gradual reduction in the circadian expression of Per2
(Figure 2B). These results suggested that E4BP4 functions
as a negative regulator of Per2 oscillation in the cell-
autonomous clock.
Two putative E4BP4-binding sites on the Per2
promoter region
Although many putative E4BP4-binding sites are located
in clock and clock-related genes (30), whether the E4BP4-
mediated negative regulation of Per2 is direct or indirect
remains unknown. To examine whether E4BP4 directly
represses the transcriptional activity of Per2, we searched
the mouse Per2 promoter region and genomic gene sequences
for the E4BP4-binding site, RT(G/T)AYGTAAY (where R
is a purine and Y is a pyrimidine) (42). Sequence analysis
Figure 1. E4BP4 is a negative regulator of Per2 transcription. (A) RNA
interference with E4BP4. NIH3T3 cells were transfected with scrambled
siRNA (Control siRNA) or specific siRNA for E4BP4 (E4BP4 siRNA).
Myc-tagged E4BP4 was co-transfected with Myc-tagged HLF (as a negative
control) 24 h later. At 48 h after siRNA transfection, the E4BP4 protein
level was determined by Western blotting using anti-Myc antibody. The same
membrane was stripped and reprobed with anti-actin antibody. (B) Knock-
down of E4BP4 increased Per2 transcription. NIH3T3 cells transfected with
siRNAs (Control siRNA or E4BP4 siRNA) or non-transfected (NT) were
analyzed for E4BP4 and Per2 mRNA by Northern blotting. Poly(A)
+ RNA
was purified from total RNA of two independent experiments. Expression
levels were normalized to those of b-actin. Values are relative to that of
NT cells.
Figure 2. E4BP4 negatively regulates Per2 oscillation in cell-autonomous
clock. (A) Effect of E4BP4-knockdown by siRNA. B, Effect of E4BP4-
overexpression. Promoter region of mPer2 ( 798 to +331 relative to the cap
site) was examined in real-time reporter gene assays. After introduction of
siRNAs (A) or E4BP4-expression vector (B), bioluminescence was measured
and integrated for 1 min at intervals of 10 min. The results are representative
of three independent experiments.
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at  151 and B-site at +197) around the TSS (Figure 3A).
The nucleotide sequences of the A- and B-sites matched
8/10 and 9/10 bp of the consensus E4BP4-binding sequence,
respectively. Further analysis revealed that the nucleotide
sequence around the A-site is highly conserved among mam-
malian Per2 promoter regions (cow, dog, human, mouse and
rat) (Figure 3B, upper panel). On the other hand, a B-site is
located at a diverse region of intron 1 (Figure 3B, lower
panel). Interestingly, the location of both sites with respect
to the E2 enhancer was highly conserved beyond species
(Figure 3C). These data suggest that the A- and B-sites are
functionally important for the E4BP4-mediated negative
regulation of Per2.
E4BP4 directly represses the transcriptional activity
of Per2 through the B-site
To understand the functional importance of the A- and B-sites
for E4BP4-mediated transcriptional repression of Per2,w e
performed luciferase assays with mutant constructs of the
mPer2 ( 798 to +331) promoter (Figure 4A) to prevent
E4BP4 binding (Supplementary Figure S1). The mutated
sequences of the A- and B-sites were 50-CCAGTGTAAA-
30 and 50-CCAGCGTAAC-30, respectively (43). E4BP4-
mediated transcriptional repression of these mutant constructs
was examined, and normalized expression level was calcu-
lated relative to the luciferase activity in the absence of
E4BP4. Consistent with the observations in Figure 2B,
exogenously expressed E4BP4 repressed the transcriptional
activity of the wild type of mPer2( 798 to +331) promoter
(Wild, % of repression by E4BP4 was 41.0%). A mutation
of the A-site (A mut; 47.2%) resulted in the same transcrip-
tional repression as with the Wild type. However, mutation of
the B-site (B mut; 9.67%) and of both the A- and B-sites (A/B
mut; 11.7%) recovered from the repression (Figure 4B).
Similar results were obtained using deletion constructs of
E4BP4-binding sites (data not shown). As the PAR trans-
cription factors (DBP, HLF and TEF) are known to bind to
the identical nucleotide sequence as E4BP4 in vitro (29,30),
we also examined the effect of DBP, HLF and TEF on the
mPer2 promoter activity using same mutant and deletion con-
structs. However, neither the A- nor B-site was responsible
for the transcriptional activation of mPer2 by these PAR
transcription factors (Supplementary Figure S2). These results
suggest that the B-site is functionally important for the
E4BP4-mediated transcriptional repression of Per2.
To clarify the importance of the B-site for E4BP4-
mediated transcriptional repression of the Per2 promoter
through the DNA-binding activity of E4BP4, we performed
gel shift assays using nuclear extracts from the NIH3T3
cells expressing Myc-tagged E4BP4 and the probes shown
in Figure 3A. We used end-labeled DNA fragments of
 200 bp containing either the A- or the B-site probes
(Figure 3A). We observed shifted bands for both probes
and the bands disappeared in the presence of an unlabeled
competitor containing the consensus E4BP4-binding
sequence, indicating that the protein-DNA complexes were
speciﬁc for the E4BP4-binding site (Figure 5A, asterisk
in probe A and double asterisk in probe B). However, the
Figure 3. Two putative E4BP4-binding sites on mammalian Per2 promoter
regions. (A) Maps of mPer2 promoter region. Arrow and oval indicate
transcription start site (TSS) and E2 enhancer (position at –20 relative to cap
site) (24), respectively. Two putative E4BP4-binding sites are shown as open
boxes. Positions of probes used for gel shift analysis are indicated as
horizontal bars. (B) Sequence alignment of region around E4BP4-binding
sites. Conserved sequences are shown as white characters on black.
Consensus E4BP4-binding sequences are shown above and identical bases
are indicated by asterisks. (C) Distance between putative E4BP4-binding sites
and E2.
Figure 4. B-site is responsible for E4BP4-mediated transcriptional repression
of Per2. (A) Schematic representation of mutant constructs of mPer2
promoter. Arrow indicates TSS. Open boxes, putative E4BP4-binding sites.
Each or both of the putative E4BP4-binding sites were mutated (A-site,
50-CTTATGTAAA-30 to 50-CCAGTGTAAA-30; B-site, 50-CTTACGTAAC-
30 to 50-CCAGCGTAAC-30). (B) Analysis of E4BP4-binding sites on
Per2 promoter. Transcriptional assay was performed with indicated mutant
constructs. E4BP4 expression plasmid is present (+) or absent ( ).
Normalized expression level was calculated relative to luciferase activity in
absence of E4BP4. Values are means ± SEM of three replicates from a single
assay. (*) Significant difference between presence versus absence of E4BP4
(P < 0.001). Results are representative of two independent experiments.
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in only probe B (Figure 5A, arrowhead). This was also con-
ﬁrmed using an anti-Myc antibody (data not shown). These
results suggest that E4BP4 binds to the B-site and forms a
DNA-protein complex. We questioned why only the probe
B (double asterisk) showed a supershifted band. Figure 3B
shows that the nucleotide sequences of A- and B-sites
were not identical. Therefore, we examined the afﬁnity of
E4BP4 for the A- and B-sites using gel shift assays, with
recombinant-E4BP4 protein and 16-bp core probes for each
site. Figure 5B and C shows that the B-site had higher afﬁnity
than the A-site for E4BP4. Further analysis determined that
the Kds for binding of the recombinat-E4BP4 to the A- and
B-sites were 2.58 and 0.579 nM, respectively (Figure 5D).
These results indicated that E4BP4 preferentially binds to
the B-site rather than to the A-site in vitro.
We then performed ChIP assays in NIH3T3 cells express-
ing Myc-tagged E4BP4 to determine the situation in vivo.
Consistent with the observations in Figure 5 in vitro, the
ChIP assays also suggested that E4BP4 binds to the B-site
much more than to the A-site on the Per2 promoter in vivo
(data not shown). Taken together, these results indicated
that E4BP4 directly represses Per2 transcription via the
B-site on the promoter.
Binding of E4BP4 correlates with negative
regulation of Per2
The circadian expression of E4BP4 is similar to that of
the anti-phase to Per2 oscillations in both the SCN and
the liver (29,33). We therefore postulated that E4BP4 plays
an important role in Per2 oscillation in the cell-autonomous
Figure 5. E4BP4 preferentially binds to B-site in vitro.( A) Gel shift analysis
using nuclear extracts from NIH3T3 cells transfected with the E4BP4-
expression vector. Positions of probes A and B are shown in Figure 3A
and competing nucleotide sequence is 50-TCGAGAAAAAATTATGT-
AACGGTC-30. * and **, band specifically bound to E4BP4-binding site;
arrowhead, supershifted band. The band specifically bound to E4BP4-binding
site in probe B (**) not but in probe A (*) was supershifted with an
anti-E4BP4 antibody. (B) Gel shift analysis using recombinant-E4BP4.
Oligonucleotide probes (A-site, 50-CGTCTTATGTAAAGAG-30; B-site,
50-CGTCTTACGTAACCGG-30) were incubated with increasing amounts
of recombinant-E4BP4 (0, 0.4, 2, 10 and 50 ng). Arrowhead, band bound
to E4BP4. (C) Quantitation of E4BP4-oligonucleotide probe complex.
(D) Determination of Kds for binding of recombinant-E4BP4 to A- and
B-sites. Recombinant-E4BP4 (10 ng) was incubated with increasing amounts
of radiolabeled 16-bp core probes for A- and B-sites. After gel electrophoresis
and autoradiography, radioactive bands corresponding to the bound and
free forms were quantified. Concentration of bound probe was plotted
against total input probe to show saturation curves. Kd values were
determined from these data on Scatchard plots. Slope of best-fit line is
equal to  1/Kd.
Figure 6. Binding of E4BP4 correlates with negative Per2 regulation.
(A) E4BP4 transcript shows anti-phase to Per2 oscillation. NIH3T3 cells
were stimulated with 100 nM dexamethasone, and mRNA was analyzed by
northern blotting. Levels of RNA were normalized to b-actin expression
and peak values of individual curves were set to 1. (B) Oscillatory binding of
E4BP4 to Per2 promoter in vivo. NIH3T3 cells were stimulated with
dexamethasone and ChIP assays of B-sites were applied. Bottom panel, Per2
mRNA oscillation. No Ab, without antibody; a-E4BP4, with anti-E4BP4
antibody.
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expression proﬁle of E4BP4 mRNA in NIH3T3 cells after
stimulation with 100 nM dexamethasone (44). Northern
blots showed rhythmic E4BP4 mRNA expression with a
peak at 36 h and a trough at 24 h, an anti-phase to Per2 oscil-
lation and a similar phase to Bmal1 oscillation (Figure 6A).
We then examined the temporal binding of endogenous
E4BP4 on the Per2 promoter by ChIP analysis. The ChIP
assay showed that the peak of endogenous E4BP4 binding
to the Per2 promoter almost matched the trough of Per2
mRNA expression (Figure 6B; see 18 and 36 h). The correla-
tion between the binding activity of E4BP4 and the trans-
criptional repression of Per2 suggests that E4BP4 plays an
important role as a negative regulator for the circadian
expression of Per2 in the cell-autonomous core clock.
B-site is responsible for the generation of high
amplitude in Per2 oscillation
To clarify the role of E4BP4 binding in Per2 mRNA oscilla-
tion in the circadian clock, we performed real-time reporter
assays using mutants of the A- and B-sites. Circadian oscilla-
tion of the construct with the wild type of mPer2 promoter
(Wild-dLuc) was obvious (Figure 7A). Superimposing the
oscillation proﬁle of the mutant construct of the A-site (A
mut-dLuc) on that of the wild type, conﬁrmed that both oscil-
lation proﬁles were similar, indicating that the A-site is
not prerequisite for the circadian expression of Per2
(Figure 7B). On the other hand, the amplitude of oscillation
by mutants of the B-site (B mut-dLuc) and of both the
A- and B-sites (A/B mut-dLuc) was lower than that of
Wild-dLuc (Figure 7C and D). These ﬁndings suggest that
the B-site is responsible for generating the high amplitude
of Per2 oscillation.
Binding of E4BP4 to the B-site is required for
circadian expression of Per2
The E2 enhancer is required for Per2 oscillation, which is
mediated by CLOCK:BMAL1 and it is located 226 bp
upstream of the B-site (24,25). To understand the relationship
between the E2 enhancer and the B-site for Per2 oscillation,
we performed real-time reporter assays using mutants of
the E2 enhancer that lack transcriptional activation by
CLOCK:BMAL1 (Supplementary Figure S3) (24). Surpris-
ingly, the mutant of the E2 enhancer (E2 mut-dLuc), which
contains both of the intact E4BP4 sites, retained the
ability to potently drive the circadian oscillation of Per2
(Figure 7E), whereas the circadian rhythmicity for the mutant
of the E2 enhancer and the B-site (E2/B mut-dLuc) as well as
the mutant of the E2 enhancer and the A/B-sites (E2/A/B
mut-dLuc) was lost (Figure 7G and H). The mutant of both
the E2 enhancer and the A-site (E2/A mut-dLuc) retained
a clear oscillatory proﬁle but it was subtly changed as
compared with E2 mut-dLuc (Figure 7F). These results
strengthened the notion that not only the E2 enhancer, but
also the B-site for E4BP4 binding is critical for the circadian
expression of Per2 mRNA in the cell-autonomous core clock.
DISCUSSION
E4BP4 is a mammalian homologue of vrille (vri) that
functions as a key negative component of the Drosophila
circadian clock (12,26,27). E4BP4 in chickens probably
plays an important role in the phase-delaying process as a
light-dependent suppressor of cPer2 (28). E4BP4 is rhythmi-
cally expressed in mammals with an anti-phase to Period1
(Per1) oscillation in the liver and the SCN and exogenously
expressed E4BP4 directly represses the Per1 promoter
Figure 7. (A–H) B-site drives the circadian expression of Per2. NIH3T3 cells were transfected with indicated mutant constructs, incubated with dexamethasone
and then bioluminescence was measured. For accurate comparison, light gray dots show bioluminescence from Wild-dLuc. Peak values of individual curves were
set to 1. Results are representative of three independent experiments that generated similar results. Wild, wild type mPer2 promoter; A mut, mutated A-site;
B mut, mutated B-site; E2 mut, mutated E2 enhancer (50-GCTAGT-30).
Nucleic Acids Research, 2007, Vol. 35, No. 2 653activity (29). These results indicated that E4BP4 functions as
a key negative component of mammalian circadian clocks
such as in Drosophila. However, no direct evidence has
supported this notion until now. This study is the ﬁrst to
demonstrate that endogenous E4BP4 negatively regulates
Per2 transcription in mammals (Figure 1B), which is consis-
tent with ﬁndings that E4BP4 represses the transcription of
several genes (42,43,45). This was also conﬁrmed in mPer2
oscillatory transcription (Figure 2A). Figure 2 shows that
the modulation of E4BP4 expression remarkably affected
the amplitude, but not the period during mPer2 oscillation.
An mPer2 mutant displays a short-circadian period followed
by a loss of circadian rhythmicity in constant darkness (20),
and our data also indicated a subtle elongation and shorten-
ing of the period induced by down- and up-regulated E4BP4
expression, respectively (Figure 2). The effect upon the
period of oscillation might depend on the expression level
and a distinguishing change in E4BP4 expression might be
required. These results show that E4BP4 is involved in the
circadian expression of Per2, which is one of the essential
components of mammalian circadian clocks.
We identiﬁed two putative E4BP4-binding sites on the
Per2 promoter region (Figure 3). Ueda et al. described
the A-site as an E4BP4-binding site that can oscillate SV40
promoter activity in a similar phase to Per2 in established
cell lines (30). Because the nucleotide sequence around the
A-site is highly conserved, the A-site has simply been thought
to play an important role. In this study, we showed that the
novel E4BP4-binding site, the B-site, is required for the
robust circadian expression of Per2 (Figures 4 and 7). Fur-
thermore, the importance of B-sites for E4BP4-mediated
transcriptional repression of Per2 is conﬁrmed by the DNA-
binding activity of E4BP4 in vitro and in vivo (Figure 5).
Different nucleotides at the center of the consensus sequence,
that is, ‘T’ and ‘C’ on the A- and B-sites, respectively, might
explain the preference for the B-site.
Yoo et al. have recently identiﬁed a circadian enhancer
(E2) with a non-canonical 50-CACGTT-30 E-box located
20 bp upstream of the mPer2 transcription start site and
demonstrated that a 210 bp promoter region with the E2
enhancer but without the B-site, is sufﬁcient for Per2 oscilla-
tion (24). Here, we performed real-time luciferase assays in
NIH3T3 cells using the mPer2 ( 798 to +331) promoter con-
taining the E2 enhancer as well as the novel E4BP4-binding
site (B-site). Our ﬁndings showed that the novel cis-element
for E4BP4 binding is required for robust circadian expression
of Per2 in the cell-autonomous core clock as well as the E2
enhancer, indicating that E4BP4 is a key negative regulator
of the mammalian circadian clock.
The Drosophila circadian oscillator consists of interloc-
ked period/timeless and dClock transcriptional/translational
feedback loops (46–49). Within these loops, VRI negatively
regulates period expression, which is activated by the
dCLOCK:CYCLE complex (CYCLE is also known as
dBMAL1), through the repression of dClock promoter
activity (12,26,27). We showed that E4BP4, which is a
mammalian homologue of vri, functions as a repressor of
Per2 transcription through the novel E4BP4-binding site
(B-site) and that E4BP4 must bind to the B-site for the robust
circadian expression of Per2 in the cell-autonomous clock.
These ﬁndings demonstrate the importance of negative
regulation by the direct binding of E4BP4 as well as of posi-
tive regulation by CLOCK:BMAL1 in the mammalian circa-
dian clock. Taken together, VRI/E4BP4 seems to function as
a negative factor of Period oscillation in the circadian clock
of Drosophila and mammals.
Missense mutations in clock genes have recently been
linked to familial advanced (50,51) and delayed (52) sleep
phase syndromes, an abnormality in the circadian timing
system that affects the timing of sleep. Here we show the
importance of negative regulation by E4BP4 for the circadian
expression of Per2. As with these clock components, the
identiﬁcation of a nucleotide polymorphism in E4BP4 should
bring new insight into sleep disorders.
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